LncRNA GClnc1 may contribute to the progression of ovarian cancer by regulating p53 signaling pathway

Ovarian cancer (OC) is one of the most prevalent and deadly types of gynecological malignancy. Since current treatments are not effective against OC, it is imperative to develop novel potential therapeutic targets for managing OC. In this study, we aimed to uncover the underlying molecular mechanism...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Hu Li, Zheng Zeng, Xiang Yang, Ye Chen, Lei He, Ting Wan
Natura: Artigo
Lingua:Inglês
Pubblicazione: PAGEPress Publications 2020-11-01
Serie:European Journal of Histochemistry
Soggetti:
lncRNA
GClnc1
p53
ovarian cancer
target therapy
Accesso online:https://ejh.it/index.php/ejh/article/view/3166
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi